Loading…
Legislative Progress
Introduced
February 27, 2019
Latest Action
December 10, 2019
Primary Sponsor
Pramila JayapalDemocratic(WA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
95pct
286d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Medicare for All Act of 2019 This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals upon birth or residency in the United States; and (3) cover items and services that are medically necessary or appropriate to maintain health or to diagnose, treat, or rehabilitate a health condition, including hospital services, prescription drugs, mental health and substance abuse treatment, dental and vision services, and long-term care. The bill prohibits cost-sharing (e.g., deductibles, coinsurance, and copayments) and other charges for covered services. Additionally, private health insurers and employers may only offer coverage that is supplemental to, and not duplicative of, benefits provided under the program. Health insurance exchanges and specified federal health programs terminate upon program implementation. However, the program does not affect coverage provided through the Department of Veterans Affairs or the Indian Health Service. The bill also establishes a series of implementing provisions relating to (1) health care provider participation; (2) HHS administration; and (3) payments and costs, including the requirement that HHS negotiate prices for prescription drugs. Individuals who are age 18 or younger, age 55 or older, or already enrolled in Medicare may enroll in the program starting one year after enactment of this bill; other individuals may buy into the program at this time. The program must be fully implemented two years after enactment.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (73)
Subcommittee Hearings Held.
Sponsor introductory remarks on measure. (CR H2709-2711)
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Military Personnel.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Rules, Oversight and Reform, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021 HR 5376 Build Back Better Act HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 HR7213 - The Equitable Community Access to Pharmacist Services Act Infrastructure Investments and Jobs Act HR8800 - Supporting Medicare Providers Act HR3173/S3018 - Improving Seniors' Timely Access to Care Act HR8188- Saving Access to Laboratory Services Act
Client expense: $145,277 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021 HR 5376 Build Back Better Act HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 HR7213 - The Equitable Community Access to Pharmacist Services Act Infrastructure Investments and Jobs Act
Client expense: $86,763 · Firm income: Not reported
2022 · second_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 7666, Restoring Hope for Mental Health and Well Being Act of 2022; issues generally pertaining to the impact of COVID-19 on hospitalists.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| House |
| Referred to |
| February 27, 2019 |
| Rules Committee | House | Referred to | February 27, 2019 |
| Education and the Workforce Committee | House | Referred to | February 27, 2019 |
| Democratic |
| TX |
| Alan S. Lowenthal | Democratic | CA |
| Alcee L. Hastings | Democratic | FL |
| Alexandria Ocasio-Cortez | Democratic | NY |
| Alma S. Adams | Democratic | NC |
| André Carson | Democratic | IN |
| Andy Levin | Democratic | MI |
| Ann Kirkpatrick | Democratic | AZ |
| Anthony G. Brown | Democratic | MD |
| Ayanna Pressley | Democratic | MA |
| Barbara Lee | Democratic | CA |
| Ben Ray Luján | Democratic | NM |
| Bennie G. Thompson | Democratic | MS |
| Bobby L. Rush | Democratic | IL |
| Bonnie Watson Coleman | Democratic | NJ |
| Brad Sherman | Democratic | CA |
| Brenda L. Lawrence | Democratic | MI |
| Brendan F. Boyle | Democratic | PA |
| Brian Higgins | Democratic | NY |
| Carolyn B. Maloney | Democratic | NY |
| Chellie Pingree | Democratic | ME |
| Daniel T. Kildee | Democratic | MI |
| Danny K. Davis | Democratic | IL |
| David E. Price | Democratic | NC |
| David N. Cicilline | Democratic | RI |
| Debbie Dingell | Democratic | MI |
| Debra A. Haaland | Democratic | NM |
| Diana DeGette | Democratic | CO |
| Dina Titus | Democratic | NV |
| Donald M. Payne, Jr. | Democratic | NJ |
| Donald S. Beyer, Jr. | Democratic | VA |
| Earl Blumenauer | Democratic | OR |
| Ed Perlmutter | Democratic | CO |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Eliot L. Engel | Democratic | NY |
| Emanuel Cleaver | Democratic | MO |
| Eric Swalwell | Democratic | CA |
| Frederica S. Wilson | Democratic | FL |
| Grace F. Napolitano | Democratic | CA |
| Grace Meng | Democratic | NY |
| Gregorio Kilili Camacho Sablan | Democratic | MP |
| Gregory W. Meeks | Democratic | NY |
| Hakeem S. Jeffries | Democratic | NY |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Ilhan Omar | Democratic | MN |
| Jackie Speier | Democratic | CA |
| Jahana Hayes | Democratic | CT |
| James P. McGovern | Democratic | MA |
| James R. Langevin | Democratic | RI |
| Jamie Raskin | Democratic | MD |
| Janice D. Schakowsky | Democratic | IL |
| Jared F. Golden | Democratic | ME |
| Jared Huffman | Democratic | CA |
| Jerrold Nadler | Democratic | NY |
| Jerry McNerney | Democratic | CA |
| Jesús G. "Chuy" García | Democratic | IL |
| Jimmy Gomez | Democratic | CA |
| Jimmy Panetta | Democratic | CA |
| Joe Neguse | Democratic | CO |
| John A. Yarmuth | Democratic | KY |
| John Lewis | Democratic | GA |
| John P. Sarbanes | Democratic | MD |
| Joseph P. Kennedy III | Democratic | MA |
| Josh Harder | Democratic | CA |
| José E. Serrano | Democratic | NY |
| Joyce Beatty | Democratic | OH |
| Juan Vargas | Democratic | CA |
| Judy Chu | Democratic | CA |
| Karen Bass | Democratic | CA |
| Katherine M. Clark | Democratic | MA |
| Katie Hill | Democratic | CA |
| Katie Porter | Democratic | CA |
| Linda T. Sánchez | Democratic | CA |
| Lloyd Doggett | Democratic | TX |
| Lois Frankel | Democratic | FL |
| Lori Trahan | Democratic | MA |
| Lucille Roybal-Allard | Democratic | CA |
| Marc A. Veasey | Democratic | TX |
| Marcia L. Fudge | Democratic | OH |
| Mark DeSaulnier | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Mark Takano | Democratic | CA |
| Matt Cartwright | Democratic | PA |
| Maxine Waters | Democratic | CA |
| Michael F. Doyle | Democratic | PA |
| Mike Levin | Democratic | CA |
| Mike Thompson | Democratic | CA |
| Nanette Diaz Barragán | Democratic | CA |
| Nita M. Lowey | Democratic | NY |
| Nydia M. Velázquez | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Peter A. DeFazio | Democratic | OR |
| Peter J. Visclosky | Democratic | IN |
| Peter Welch | Democratic | VT |
| Rashida Tlaib | Democratic | MI |
| Raúl M. Grijalva | Democratic | AZ |
| Ro Khanna | Democratic | CA |
| Robert C. "Bobby" Scott | Democratic | VA |
| Robin L. Kelly | Democratic | IL |
| Ruben Gallego | Democratic | AZ |
| Salud O. Carbajal | Democratic | CA |
| Sheila Jackson Lee | Democratic | TX |
| Steve Cohen | Democratic | TN |
| Susan Wild | Democratic | PA |
| Suzanne Bonamici | Democratic | OR |
| Ted Lieu | Democratic | CA |
| Tim Ryan | Democratic | OH |
| Tulsi Gabbard | Democratic | HI |
| Veronica Escobar | Democratic | TX |
| Vicente Gonzalez | Democratic | TX |
| William R. Keating | Democratic | MA |
| Wm. Lacy Clay | Democratic | MO |
| Yvette D. Clarke | Democratic | NY |
| Zoe Lofgren | Democratic | CA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021 HR 5376 Build Back Better Act HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 The Infrastructure Investments and Jobs Act
Client expense: $121,540 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act/ P.L. 117- 71, Protecting Medicare and American Farmers from Sequester Cuts Act; issues generally pertaining to the impact of COVID on hospitalists.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medicare/Medicaid
HR 5376 Build Back Better Act HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 The Infrastructure Investments and Jobs Act
Client expense: $110,671 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019; H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act/ P.L. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medicare/Medicaid
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021 Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763 The Infrastructure Investments and Jobs Act Build Back Better Act
Client expense: $113,175 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medicare/Medicaid
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
Client expense: $115,673 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019. Health care policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Medicare/Medicaid
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes. HR 3502 - Protecting People from Surprise Medical Bills Act HR 3630 - to amend title XXVII of the Public Health Service Act HR 1384 - Medicare for All Act of 2019 HR 861 - End Surprise Billing Act of 2019 S 1266 - Protecting Patients from Surprise Medicare Bills Act S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019 S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 HR 345 - SMASH Act S 1213 - Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patents VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
Client expense: $137,521 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Medicare/Medicaid
Medicare Access and CHIP Reauthorization Act (PL 114-10) S.2157, Rural Hospital Sustainability Act: CMMI payment model to rural hospitals H.R.1763, Resident Physician Shortage Reduction Act of 2019:residency positions eligible for graduate medical education payments H.R. 1384, Medicare for All Act of 2019: Medicare for All H.R. 4056, Medicare Audiologist Access and Services Act of 2019: audiology H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act of 2018: Opioids H.R. 6, SUPPORT for Patients and Communities Act: Opioids H.R. 2550, Medicare Telehealth Parity Act of 2017 H.R. 676, Expanded and Improved Medicare for All Act: Medicare for All, payment H.R. 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020: payment H.R. 8756, COVID Health Care Provider Assurance Act of 2020: payment H.R. 315, Medicare Sequester COVID Moratorium Act: Medicare sequester, PAYGO Independent Payment Advisory Board (IPAB) Repeal Rural Anesthesiology: Rural Pass Through Out of Network/Out of Network Payment Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Perioperative Surgical Home Model Bundled payments CMS 45 CFR Parts 147, 155, and 156, PPACA; Market Stabilization rule CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services 2017 Medicare Physician Fee Schedule Rule CMS decision to decrease values of interlaminar epidural injections CMS Value-Based purchasing CMS Medicare Data Final Rule Sunshine Act Implementation Conditions of Participation - Anesthesia services, opt-outs, supervision Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation IPAB cuts Graduate Medical Education Value-based modifier - PPACA Debt ceiling - Medicare sequestration QCDR - Qualified Clinical Data Registry CMS Meaningful Use Stage 3 Executive Order Promoting Healthcare Choice and Competition (Trumpcare) Ambulatory Surgery Center Critical Care and Anesthesia Services Payment Reform: Increase payments for anesthesia and critical care services for Medicare COVID patients Prescription Drug Management Programs: Evaluation and Monitoring codes & cuts Certified Anesthesiologist Assistants Public Option
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2021 · first_quarter · Health Issues
H.R. 1384/S. 445, the Mainstreaming Addiction Treatment Act of 2019. Health care policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and health care policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · second_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $2,160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Most Favored Nation (MFN) Model - (CMS-5528-IFC)
Client expense: $1,090,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · third_quarter · Health Issues
Assisted living Facilities legislation, HR 1384/S 1804-Medicare for all Act, Covid 19-response package/surprise billing,
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2020 · third_quarter · Health Issues
Assisted living Facilities legislation, HR 1384/S 1804-Medicare for all Act, Covid 19-response package/surprise billing,
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2020 · first_quarter · Health Issues
S.80, Jobs and Premium Protection Act (all provisions) S.172, Health Insurance Tax Relief Act (all provisions) S.340, CREATES Act (all provisions) S.684, Middle Class Health Benefits Tax Repeal Act (all provisions) S.1531, Stopping the Outrageous Practice of Surprise Medical Bills Act (all provisions) S.1895, Lower Health Care Costs Act S.1510, Employee Flexibility Act (all provisions) S.2366, Commonsense Reporting Act (all provisions) HR 748, Middle Class Health Benefits Tax Repeal Act (all provisions) HR 861, End Surprise Billing Act (all provisions) HR 965, CREATES Act (all provisions) HR 1384, Medicare for All Act (all provisions) HR 1398, Health Insurance Tax Relief Act (all provisions) HR 3630, No Surprises Act HR 2782, Employee Flexibility Act (all provisions) HR 4070, Commonsense Reporting Act (all provisions) HR 3502, Protecting People From Surprise Medical Bills Act (all provisions) S.2543 Prescription Drug Pricing Reduction Act (all provisions) H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (all provisions) H.R. 1994, the Setting Every Community Up for Retirement Enhancement (SECURE) Act (all provisions)
Client expense: $1,845,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Federal Maritime Commission, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office
2020 · second_quarter · Health Issues
HR 6395, National Defense Authorization Act S. 4049, National Defense Authorization Act HR 6666, COVID 19 Testing, Reaching and Contacting Everyone Act (TRACE Act) HR 1425, Patient Protection and Affordable Care Enhancement Act HR 6514, Worker Health Coverage Protection Act HR 6568, Coverage for COVID 19 Treatment Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act (CARES Act) HR 6201, The Families First Coronavirus Response Act HR 5438, Cox, The End Valley Fever Now Act S. 2897, Warner, regarding the reauthorization of PCORI HR 5201, Matsui, regarding telehealth and behavioral health HR 2328, PCORI Reauthorization HR 2328, the No Surprises Act S. 1895, the Lower Health Care Costs Act HR 987 and S. 455, regarding outreach and education activities under the ACA HR 3439, regarding the reauthorization of PCORI House Resolution 271, regarding the Justice Departments position in Texas v. United States HR 2062 & S. 1012, regarding 42 CFR Part 2 and confidentiality of certain health information HR 1884, with provisions to stabilize and strengthen the ACA and the nongroup insurance market. S. 470, regarding a Medicare buy-in option for individuals aged 50-64 S. 489 and HR 1277, regarding a Medicaid buy-in option S. 1129, to establish a single payer system based on Medicare for All. HR 1384, to establish a single payer health care system HR 1425, regarding reinsurance funding under the ACA HR 986 and S. 466, regarding Section 1332 state waiver guidance. HR 1010, regarding Short Term Limited Duration Insurance policies HR 1143, regarding Short Term Limited Duration Insurance policies HR 861, regarding surprise billing
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
S.2846 & H.R.3935 - Protecting Patients Transportation to Care Act S.1129 & H.R.1384 - Medicare for All Act of 2019 S.1423 & H.R.1393 - Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2019 S.22 & H.R.2951 - Medicare Dental Benefit Act of 2019 H.R.4650 - Medicare Dental Coverage Act of 2019 H.R.8118 - Foster Youth Dental Act of 2020 H.R.576 - Seniors Have Eyes, Ears, and Teeth Act
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Occupational Safety & Health Administration (OSHA), SENATE, Treasury, Dept of
2020 · fourth_quarter · Small Business
H.R. 3 - Lower Drug Costs Now Act of 2019 This bill establishes several programs and requirements relating to the prices of prescription drugs. NSBA is monitoring. H.R. 25 - The Fair Tax Act To promote freedom, fairness, and economic opportunity by repealing the income tax and other taxes, abolishing the Internal Revenue Service, and enacting a national sales tax to be administered primarily by the states. NSBA supports H.R. 116 - Investing in Main Street Act The bill amends the Small Business Investment Act of 1958 to increase from 5 percent to 15 percent of its capital and surplus, the amount a national bank, a member bank of the Federal Reserve System, a nonmember insured bank (to the extent permitted under applicable state law), or a federal savings association may invest in one or more small business investment companies (SBICs), or in any entity established to invest solely in SBICs. NSBA is monitoring. H.R. 128 - Small Business Advocacy Improvements Act H.R. 128 allows the SBA Office of Advocacy to examine the role of small business in international economies and to represent small business views before foreign governments and international entities. NSBA is monitoring. H.R.133 - Consolidated Appropriations Act, 2021 Omnibus spending bill which included $900 billion in COVID relief, specifically a new round of lending under the Paycheck Protection Program (PPP). NSBA supports the small business provisions. H.R. 190 - Expanding Contracting Opportunities for Small Business Act H.R. 190 raises the dollar amount of sole-source awards so that they are closer in line with the size of current contracts being awarded in the procurement landscape. NSBA supports. H.R. 206 - Encouraging Small Business Innovators Act H.R. 206 makes a series of changes to the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, making them easier for small firms to use. NSBA supports. H.R. 216 - Main Street Certainty Act of 2019 Legislation to make permanent the 20-percent pass-through deduction from the Tax Cuts and Jobs Act. NSBA supports. H.R. 218 - The Death Tax Repeal Act This bill repeals the federal estate, gift, and generation-skipping transfer taxes. NSBA supports. H.R. 222 - Death Tax Repeal Act of 2019 This bill repeals the federal estate, gift, and generation-skipping transfer taxes. NSBA supports. H.R. 226 - Clarity on Small Business Participation in Category Management Act H.R. 226 requires the SBA to report federal spending made through designated best-in-class vehicles, and to report on the dollars spent through these vehicles awarded to small businesses. NSBA supports. H.R. 227 - Incentivizing Fairness in Subcontracting Act Bill allows large prime contractors to take credit for subcontracting to small businesses at lower tiers, provided that prime contractors keep records substantiating subcontracting credit claimed at lower tiers, and creates a new dispute process for small subcontractors to bring non-payment issues to the agencys small business advocate (Offices of Small and Disadvantaged Business Utilization). NSBA supports. H.R. 246 - Stimulating Innovation through Procurement Act The bill requires SBA to coordinate with the senior procurement executives of federal agencies participating in a Small Business Innovation Research (SBIR) Program or a Small Business Technology Transfer (STTR) Program to assist small businesses participating in such programs with commercializing research. NSBA supports. H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019 Bill requires the federal government to negotiate lower drug prices for seniors enrolled in the Medicare Part D program. NSBA is monitoring. H.R. 448 - The Medicare Drug Price Negotiation Act Bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs). NSBA is monitoring. H.R. 582 - The Raise the Wage Act This bill amends the Fair Labor Standards Act of 1938 to increase the federal minimum wage for regular employees over a 7-year period, for tipped employees, and for newly hired employees who are less than 20 years old. NSBA opposes. H.R. 593 - Small Business Owners' Tax Simplification Act of 2019H.R. 593 introduces a number of provisions to benefit small businesses, such as aligning estimated payment deadlines and tax filing thresholds, as well as tackling inconsistencies in reporting requirements. NSBA supports. H.R. 1046 - The Medicare Negotiation and Competitive Licensing Act of 2019 Bill would authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices and, if drug companies refuse to negotiate in good faith, it would enable the Secretary to issue a competitive license to another company to produce the medication as a generic. NSBA is monitoring. H.R. 1084 - Family Savings Act of 2019 It includes a variety of provisions aimed at making it easier for smaller businesses to offer tax-qualified retirement savings plans to their employees, encouraging individuals to participate in retirement plans, and promoting savings for nonretirement expenses. NSBA is monitoring. H.R. 1185 - The Family and Medical Insurance Leave (FAMILY) Act Legislation which provide workers with up to 12 weeks of partial income while taking family leave. NSBA opposes. H.R.1384 - Medicare for All Act of 2019 H.R. 1384 would create a single-payer, government-funded health care program within two years, eliminating the age 65 threshold for Medicare eligibility. NSBA is monitoring. H.R. 1420 - Energy Efficient Government Technology Act This bill sets forth requirements with respect to increasing the energy efficiency of information technologies and data centers within the federal government. NSBA is monitoring. H.R. 1534 - Federal Employee Paid Leave Act of 2019 Bill would provide federal employees with 12 weeks paid leave for all instances covered by FMLA. NSBA opposes. H.R. 1644 - Save the Internet Act of 2019 Bill would restore net neutrality rules recently repealed by the Federal Communications Commission (FCC). NSBA supports. H.R. 1648 - Small Business Advanced Cybersecurity Enhancements Act of 2019 Amends the Small Business Act to provide for the establishment of an enhanced cybersecurity assistance and protections for small businesses. NSBA supports. H.R. 1649 - Small Business Development Center Cyber Training Act This bill amends the Small Business Act to require the Small Business Administration to establish a program for certifying employees of small business development centers to provide cybersecurity planning assistance to small businesses. NSBA supports. H.R. 1760 - Advanced Nuclear Fuel Availability Act This bill directs the Office of Nuclear Energy in the Department of Energy to develop and deploy high-assay low-enriched uranium for domestic commercial use and to develop a schedule for recovering costs associated with such development. NSBA is monitoring. H.R. 1768 - Diesel Emissions Reduction Act of 2019 This bill reauthorizes through FY2024 a diesel emissions reduction program under which the Environmental Protection Agency provides grants, rebates, or loans for replacing diesel engines or retrofitting the engines with pollution control technologies. NSBA is monitoring. H.R. 1784 - Healthy Families Act Legislation that would allow workers to annually accrue up 56 hours of paid sick leave or seven days of paid sick leave each year. NSBA opposes. H.R. 1909 - The HALOS Act This bill directs the Securities and Exchange Commission (SEC) to revise Regulation D, which exempts certain offerings from SEC registration requirements but prohibits general solicitation or general advertising with respect to such offerings. NSBA supports. H.R. 1922 - Restoring Access to Medication Act of 2019 This bill repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that limit payments for medications from health savings accounts, medical savings accounts, health flexible spending arrangements, and health reimbursement arrangements to only prescription drugs or insulin (thus allowing distributions from such accounts for over-the-counter drugs). The bill also allows the accounts to be used for menstrual care products. NSBA supports. H.R. 1927 - Separation of Powers Restoration Act of 2019 This bill modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo (without giving deference to the agency's interpretation) all relevant questions of law, including the interpretation of: (1) constitutional and statutory provisions, and (2) rules made by agencies. NSBA supports. H.R. 1933 - Online Sales Simplicity and Small Business Relief Act of 2019 This bill prohibits states from imposing a sales tax collection duty on certain remote sellers. A "remote seller" is a person without a physical presence in a state who makes a sale in the state. NSBA is monitoring. H.R. 2114 - Enhancing State Energy Security Planning and Emergency Preparedness Act of 2019 The bill authorizes the Department of Energy (DOE) to provide financial assistance to states for the implementation, review, and revision of a state energy security plan that assesses the state's existing circumstances and proposes methods to strengthen the ability of the state to have a reliable, secure, and resilient energy infrastructure. NSBA is monitoring. H.R. 2331 - The SBA Cyber Awareness Act It require the SBA to report annually to the Congress on the state of its information technology (IT) and cybersecurity systems, the methods it could use to improve cybersecurity, any IT equipment or systems it has that were produced by an entity doing business principally in China, and any recent cybersecurity risks or incidents and subsequent responses. NSBA supports. H.R. 2345 - Clarifying the Small Business Runway Extension Act Amend the Small Business Act to clarify the intention of Congress that the Administrator of the Small Business Administration is subject to certain requirements with respect to establishing size standards for small business concerns. NSBA is monitoring. H.R. 2513 - The Corporate Transparency Act of 2019 Bill would amend the Bank Secrecy Act to require an applicant seeking to form a corporation or limited liability company (LLC) to disclose the beneficial owners of the entity. NSBA opposes the small business requirements section of the bill. H.R. 2603 - the Northern Mariana Islands Small Business Act Gives the Northern Mariana Islands full access to SBA grant and microloan programs. NSBA supports. H.R. 3630 - The No Surprises Act This bill expands restrictions on charging health care plan holders out-of-network rates for certain services. NSBA is monitoring. H.R. 3666 - STRONGER Patents Act of 2019 Measure would make it easier and more affordable for patent holders to enforce their patents. NSBA supports. H.R. 4069 - The Modern Worker Empowerment Act Amend the FLSA to adopt a common-law test to define the term employee. The bill would have the effect of harmonizing the definition of employee for purposes of federal law and thereby minimizing the uncertainty surrounding the determination as to whether an individual is an employee or independent contractor. NSBA is monitoring. H.R. 4387 - To establish Growth Accelerator Fund Competition within the Small Business Administration H.R. 4387 codifies the SBA-initiated Growth Accelerator Fund Competition within the SBA for four years. The program awards $50,000 prizes to the nations most innovative small business accelerators and incubators. NSBA supports. H.R. 4405 - Women's Business Centers Improvements Act of 2019 The Womens Business Centers Improvements Act strengthens the WBC program to ensure that women entrepreneurs across the country have access to the vital counseling and technical training services that can take them from startup to success. NSBA supports. H.R. 4406 - Small Business Development Centers Improvement Act of 2019 This bill reauthorizes the Small Business Development Center Program through FY2023 and otherwise revises the program. NSBA supports. H.R. 4407 - SCORE for Small Business Act of 2019 This bill reauthorizes through FY2022 the Service Corps of Retired Executives (SCORE) program, outlines the duties of the SCORE Association, and requires the Small Business Administration (SBA) to cooperate with the association to carry out the program. NSBA supports. H.R. 4863 - United States Export Finance Agency Act of 2019 To promote the competitiveness of the United States, to reform and reauthorize the United States Export Finance Agency. NSBA supports. H.R. 4907 - TRUST Act The bill establishes bipartisan commissions to make recommendations on each trust fund, and those recommendations would receive a fast-tracked vote in Congress. NSBA is monitoring. H.R. 4931 - Incubator Act of 2019 The purposes for this Act are to support the growth and success of business incubators throughout the country and to stimulate widespread business development and economic growth. NSBA is monitoring. H.R. 5065 - the Prison to Proprietorship Act for Formerly Incarcerated Act H.R. 5065 provides re-entry entrepreneurship counseling and training services for formerly incarcerated individuals. NSBA supports. H.R. 5078 - the Prison to Proprietorship Act H.R. 5078 provides re-entry entrepreneurship counseling and training services for qualified, non-violent and soon to be released incarcerated individuals. NSBA supports. H.R. 5130 - the Capturing All Small Businesses Act of 2019 H.R. 5130 modifies the Small Business Administrations (SBAs) size calculation for employee based firms, allowing them more time to build their competitiveness. NSBA supports. H.R. 5146 - the Unlocking Opportunities for Small Businesses Act of 2019 H.R. 5146 would allow small businesses to leverage past performance experience obtained as part of joint ventures and subcontracts, which otherwise wouldnt be an option, Small businesses that wish to perform as prime contractors are often faced with a dilemma. NSBA supports. H.R. 5377 - Restoring Tax Fairness for States and Localities Act This bill increases the tax deduction for state and local taxes in 2019 to $20,000 for persons filing a joint tax return if the adjusted gross income of the taxpayer does not exceed $100 million. NSBA is monitoring. H.R. 6312 - COVID-19 RELIEF for Small Businesses Act of 2020 Legislation that would provide relief to small businesses facing consequences from the ongoing COVID-19 outbreak. NSBA is monitoring. H.R. 6333 - To establish a Small Business Financial Assistance Program to support small businesses during the COVID-19 emergency, and for other purposes. This bill requires the Department of the Treasury to establish a Small Business Financial Assistance Program to provide loans and loan guarantees to small businesses. NSBA is monitoring. H.R. 6349 - Continuity of Business Operations Support Act of 2020 This bill requires the Small Business Administration (SBA) to provide grants to small business development centers, women's business centers, and chapters of the Service Corps of Retired Executives to educate and advise small businesses on specified matters related to COVID-19 (i.e., coronavirus disease 2019). NSBA is monitoring. H.R. 6361 - Relief for Small Businesses and Nonprofits Act Bill to provide loan and obligation payment relief for small businesses and non-profits affected by the COVID-19 emergency, and for other purposes. NSBA is monitoring. H.R. 6367 - Entrepreneurial Development COVID-19 Response Act of 2020 This bill requires the Small Business Administration to award grants for small business development centers, women's business centers, and chapters of the Service Corps of Retired Executives to provide small businesses with specified assistance related to COVID-19 (i.e., coronavirus disease 2019). NSBA is monitoring. H.R.6395 - National Defense Authorization Act for Fiscal Year 2021 This bill authorizes FY2021 appropriations and sets forth policies for Department of Defense (DOD) programs and activities. NSBA opposes the beneficial ownership provisions. H.R. 6396 - To provide tax and regulatory relief and health care flexibility to individuals and businesses affected by the 2020 coronavirus pandemic. NSBA is monitoring. H.R.8900 - Further Continuing Appropriations Act, 2021, and Other Extensions Act Bill moves the government funding deadline from Dec. 11 to Dec. 18, in addition to providing a one-week extension for certain health programs. NSBA supports. S. 92 - Regulations from the Executive in Need of Scrutiny Act of 2019 The REINS Act seeks to restore authority to Congress by allowing lawmakers to have final say on regulations with an estimated economic impact of more than $100 million. NSBA supports. S. 215 - Death Tax Repeal Act of 2019 This bill amends the Internal Revenue Code to: (1) repeal the estate and generation-skipping transfer taxes, and (2) make permanent the maximum 35% gift tax rate and the lifetime gift tax exemption. The bill also provides for an inflation adjustment to such exemption amount. NSBA supports. S. 463 - The Family and Medical Insurance Leave (FAMILY) Act Legislation which provide workers with up to 12 weeks of partial income while taking family leave. NSBA opposes. S. 673 - Expanding Contracting Opportunities for Small Businesses Act of 2019 Bill increases the size of sole source contract awards for women owned, service-disabled veteran-owned, HUBZone, and socially and economically disadvantaged small businesses, and implements a new eligibility determination process to ensure sole source awards are made to eligible firms. NSBA supports. S. 682 -Save the Internet Act of 2019 Bill would restore net neutrality rules recently repealed by the Federal Communications Commission (FCC). NSBA supports. S. 771 - Small Business Cyber Training Act of 2019 This bill amends the Small Business Act to require the Small Business Administration to establish a program for certifying employees of small business development centers to provide cybersecurity planning assistance to small businesses. NSBA supports. S. 840 - Healthy Families Act Legislation that would allow workers to annually accrue up 56 hours of paid sick leave or seven days of paid sick leave each year. NSBA opposes. S. 909 - Separation of Powers Restoration Act This bill modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo (without giving deference to the agency's interpretation) all relevant questions of law, including the interpretation of: (1) constitutional and statutory provisions, and (2) rules made by agencies. NSBA supports. S. 996 - Microloan Program Enhancement Act of 2019 Bill modifies the microloan program of the Small Business Administration. NSBA supports. S. 1089 - Restoring Access to Medication Act of 2019 This bill repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that limit payments for medications from health savings accounts, medical savings accounts, health flexible spending arrangements, and health reimbursement arrangements to only prescription drugs or insulin (thus allowing distributions from such accounts for over-the-counter drugs). The bill also allows the accounts to be used for menstrual care products. NSBA supports. S. 1120 - The Small Business Regulatory Flexibility Improvements Act Bill requires federal agencies to analyze the full impact of a proposed regulation on small businesses during the rulemaking process. NSBA supports. S. 1149 - Main Street Certainty Act of 2019 Legislation to make permanent the 20-percent pass-through deduction from the Tax Cuts and Jobs Act. NSBA supports. S. 1981 - The Women and Minority Equity Investment Act of 2019 Allows women-owned federal contracting firms to take investment by women-owned equity firms and still meet the 51 percent unconditionally owned and controlled standard set by SBA to participate in the WOSB/EDWOSB program. NSBA is monitoring. S.2082 - Support Technology and Research for Our Nation's Growth and Economic Resilience Patents Act Measure would make it easier and more affordable for patent holders to enforce their patents. NSBA supports. S. 2156 - S Corporation Modernization Act Legislation that would make several pro-growth reforms to help S corporations operate more easily, which would improve their ability to raise capital. NSBA supports. S. 2189 - Veteran Small Business Export Promotion Act The Veteran Small Business Export Promotion Act would make permanent the U.S. Small Business Administrations (SBA) current policy of waiving up-front fees for veterans applying for its Export Express, Export Working Capital and International Trade loans of $150,000 or less. NSBA supports. S. 2350 - Online Sales Simplicity and Small Business Relief Act of 2019 This bill prohibits states from imposing a sales tax collection duty on a remote seller for any sale that occurred prior to June 21, 2018. A "remote seller" is a person without a physical presence in a state who makes a sale in the state. NSBA is monitoring. S. 2535 - Enhancing Entrepreneurship for the 21st Century Act This bill requires the Department of Commerce to conduct an assessment and analysis of the reasons underlying the decreasing rate of formation of new businesses (i.e., startups) in the United States. NSBA supports. S. 2543 - Prescription Drug Pricing Reduction Act of 2019 Amends titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. NSBA is monitoring. S. 2563 - ILLICIT CASH Act To improve laws relating to money laundering. NSBA opposed TITLE IV of the bill regarding beneficial ownership. S. 2733 - TRUST Act The bill establishes bipartisan commissions to make recommendations on each trust fund, and those recommendations would receive a fast-tracked vote in Congress. NSABA is monitoring. S. 3508 - Disaster Protection for Workers' Credit Act of 2020 Legislation will provide for an immediate four-month moratorium on all negative credit reporting and longer protections for people who face lasting financial hardship from the outbreak. The bill will also provide free, unlimited credit reports and credit scores for a year from the end of the crisis. Beyond this crisis, the bill extends these protections to people impacted by future major disasters. NSBA is monitoring. S. 3515 - New Business Preservation Act The New Business Preservation Act which would create a new program at the Treasury Department that will partner with states to invest in promising new businesses alongside private investors in areas of the country that do not currently attract significant equity investment in new businesses. NSBA is monitoring. S. 3518 - COVID-19 Recovery Grants for Small Businesses Act This bill requires the Small Business Administration to provide economic injury grants to certain small businesses, private nonprofit organizations, and small agricultural cooperatives that have suffered a substantial economic injury as a result of COVID-19 (i.e., coronavirus disease 2019). NSBA is monitoring. S. 3519 - A bill to authorize the Administrator of the Small Business Administration to subsidize payments on loans guaranteed under the 7(a) and 504 loan programs or made using funds under the microloan program, and for other purposes. This bill requires the Small Business Administration (SBA) to pay the principal, interest, and any associated fees owed on certain loans made to small businesses for a six month period. NSBA is monitoring. S. 3524 - Coronavirus Credit Expansion Act This bill increases the maximum loan amount for a small business disaster loan made in response to COVID-19 (i.e., coronavirus disease 2019), and it requires the Small Business Administration to expedite the loan approval process for such loans. NSBA supports. S. 3531 - Small Business Relief from Communicable Disease Induced Economic Hardship Act of 2020 This bill expands the definition of a disaster for which the Small Business Administration (SBA) may provide disaster loans to small business concerns to include communicable diseases for which the government issues a travel alert or travel warning, and it authorizes the SBA to make interest free disaster loans to small businesses affected by a disaster for which the government issues a public health emergency. NSBA is monitoring. S.3541 - A bill to modify requirements relating to small business disaster loans made in response to COVID-19, and for other pu
Client expense: $24,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Council of Economic Advisers (CEA), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Export-Import Bank of the United States (EXIM Bank), Federal Reserve System, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 (P.L. 114-10) including policies related to the Quality Payment Program Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health Medicare Shared Savings Program beneficiary assignment requirements Medicare-Medicaid hospital conditions of participation Evaluation of the Medicare Graduate Nurse Education demonstration Medicare-Medicaid Program Integrity policies Medicaid maintenance of effort requirements Medicaid eligibility expansion and state options Medicaid waiver application procedures Medicaid per capita cap policy options Promoting Access to Diabetic Shoes Act (H.R. 808/S. 237) ACO Assignment Improvement Act of 2019 (H.R. 900) Medicare for All Act of 2019 (H.R. 1384) Protecting Patients Transportation to Care Act (H.R. 3935/S. 2846) Strengthening Innovation in Medicare and Medicaid Act (H.R. 5741) Home Health Care Planning Improvement Act of 2019 (S. 296/H.R. 2150) Childrens Health Insurance Program Pandemic Enhancement and Relief (CHIPPER) Act (S. 3881/H.R. 6797)
Client expense: Not reported · Firm income: $24,000
Government targets: Bureau of Alcohol Tobacco Firearms & Explosives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
H.R. 1384, Medicare for All Act of 2019, in support of increasing access to quality, affordable health care.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), White House Office
2020 · fourth_quarter · Health Issues
Patient Protection and Affordable Care (P.L. 111-148) and Health Care Education Reconciliation Act of 2010 (P.L. 111-152); ACA reporting requirements; ERISA; tax treatment of employer-sponsored health coverage; employer-sponsored wellness programs; surprise medical billing reform; S.12/H.R 603 & H.R. 457, Health Savings Account modernization; H.R 1384, Medicare for All Act; H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019; S. 1985, Lower Health Care Costs Act; H.R. 2782/S.1510, Employee Flexibility Act; H.R. 1884, Protecting Pre-Existing Conditions and Making Health Care More Affordable Act; FDA-2019-N-1482; Comments on Cannabis or Cannabis-Derived Compounds; H.R. 3502, Protecting People from Surprise Medical Bills Act; H.R. 3630, No Surprises Act; H.R. 4070/S. 2366, Commonsense Reporting Act; H.R. 3, Lower Drug Costs Now Act; Further Consolidated Appropriations Act; Health Care Transparency; COVID-19/CARES Act; H.R. 7008, the Family Savings Flexibility Act
Client expense: $590,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Discussions on drug pricing, 340b, and price transparency policies, as well as the International Pricing Index ANPRM; Discussions about the work of Aligning for Health to address social determinants of health; Support HR 1041 / S 586,Critical Access Hospital Relief Act of 2019, a bill to amend title XVIII of the Social Security Act to remove the 96-hour physician certification requirement for inpatient critical access hospital services; Support S 895, Rural Hospital Regulatory Relief Act of 2019, a bill to provide for a permanent extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals; Support S 948,Conrad State 30 and Physician Access Reauthorization Act, a bill to provide incentives to physicians to practice in rural and medically underserved communities, and for other purposes; Discussions in support of the Rural Emergency Medical Center Act (REACH) Act; Support for extension of the Rural Community Hospital Demonstration Program; Support for extension of the Frontier Community Health Integration Project Demonstration program; Discuss changes with House and Senate committees to Section 8122 of the SUPPORT for Patients and Communities Act; Letter of support to Energy and Commerce Committee for the hearing on legislation to strengthen our health care system and ACA market stability; Support HR 1781/ S 801, Payment Commission Data Act of 2019, a bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information; Support S 551 Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019, a bill to amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program to provide rebates with respect to amounts of such drugs discarded, and for other purposes; Support S 824/ HR 1767, Excellence in Mental Health and Addiction Treatment Expansion Act, a bill to increase the number of States that may conduct Medicaid demonstration programs to improve access to community mental health services; Statement submitted to Senate Finance Committee on the implementation of the Quality Payment Program (QPP) created by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); Support HR 2552Protecting Local Access to Care for Everyone Act of 2019 or the PLACE Act of 2019, a bill to direct the Secretary of Health and Human Services to prevent certain payment reductions for clinic visit services furnished at excepted off-campus outpatient departments of a provider under the Medicare program; Support HR 3022, Patient Access Protection Act, a bill to amend title XIX of the Social Security Act to repeal the reductions in Medicaid DSH allotments, and for other purposes; Letter of support to the Ways and Means Committee in support of legislation to improve the quality of an access to services for Medicare beneficiaries, help train the physician workforce and reduce administrative burden on rural hospitals; Support HR 3431, HEARTS and Rural Relief Act, a bill to provide for the extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals through 2021; Support HR 3417,Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 or the BETTER Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for patient improvements and rural and quality improvements under the Medicare program; Oppose HR 1384, Medicare for All Act of 2019, a bill to establish an improved Medicare for All national health insurance program; Oppose S 1129, Medicare for All Act of 2019, a bill to establish a Medicare-for-all national health insurance program; Letter to House Committee on Ways and Means for the hearing on Pathways to Universal Health Coverage addressing concerns with Medicare for All and believe that the variety of proposals that often are used interchangeably under that name are not the solution; Oppose HR 2452, Medicare for America Act of 2019, a bill to amend the Social Security Act to establish a Medicare for America health program to provide for comprehensive health coverage for all Americans; Letter to House Committee on Budget for the hearing on the Congressional Budget Offices (CBO) Key Design Components and Considerations for Establishing a Single-Payer Health Care System addressing concerns with Medicare for All; Oppose S 1261/ HR 2463, Choose Medicare Act, a bill to provide for the establishment of Medicare part E public health plans, and for other purposes; Oppose S 981/ HR 2000Medicare-X Choice Act of 2019A bill to establish a public health plan; Oppose S 1033/ HR 2085, CHOICE Act, a bill to amend the Public Health Service Act to establish a public health insurance option, and for other purposes; Oppose S 470, Medicare at 50 Act, a bill to amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare; Oppose HR 1346, Medicare Buy-In and Health Care Stabilization Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes; Submitted Statement to the House Committee on Rules for the Hearing Medicare for All Act of 2019; Comment on provisions of HR 2328,Reauthorizing and Extending Americas Community Health (REACH) Act, support for the Medicaid disproportionate share hospital(DSH) program provisions included in Title III; comments on Title IV, which contains provisions of the No Surprises Act and concern with the legislations approach to determining reimbursement for out-of-network providers; Support HR 3107 Seniors Timely Access to Care Act of 2019, this legislation would establish requirements for the use of prior authorization under Medicare Advantage plans; Meeting with the Senate finance committee to discuss changes to drug bill; Meeting with CMS to discuss changes to prior authorization; Meeting with Department of Labor to discuss issues with ERISA health plans; Met with CMS staff on rural hospital issues; Regulatory burden related to new CMS guidance on documenting Crossover bad debt; Sent a Comment letter to CMS on a final rule on program integrity enhancements to the provider enrollment process for Medicare, Medicaid and Children's Health Insurance Programs; Oppose S. 2860 Patient Access to Higher Quality Health Care Act of 2019, a bill to repeal changes made by health care reform laws to the Medicare exception to the prohibition on certain physician referrals for hospitals, and for other purposes; Support HR 4996, Helping MOMS Act of 2019, a bill amend title XIX of the Social Security Act to provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individuals, and for other purposes; Addressing hospital concerns about HR 3 Lower Drug Costs Now Act, a bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes; Sent comment letter requesting that CMS withdraw the proposed regulation related to Medicaid Program: Medicaid Fiscal Accountability Regulation ( MFAR) financing and supplemental payments. Given that the proposal would severely curtail the availability of health care services to millions of individuals and because many of its provisions are not legally permissible; Discussion with CMS for rural hospitals and critical access hospitals about the Medicare accelerated payment program, which is intended to provide necessary funds to providers, including rural hospitals and critical access hospitals, when there is a disruption in claims submission and/or claims processing; Submitted comments on CMSs proposed rule on Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The letter focuses on several proposals addressing network adequacy; Letter sent to HHS, CDC, CMS, and SAMHSA requesting specialized guidance and assistance for providers who care for patients with behavioral health disorders; Support resetting the Improving Medicare Post- Acute Care Transformation (IMPACT) Act of 2014 in the next COVID-19 relief package. The IMPACT Acts implementation is behind schedule and does not take into account extensive payment reforms already underway in each post-acute care setting; Letter urging HHS to release substantial additional emergency funds to all hospitals in an expedited manner. This second wave of funding to all hospitals, targeted relief is necessary for hospitals in hot spots, hospitals with a high percentage of payments under Medicare Advantage, hospitals caring for high numbers of Medicaid patients, and rural hospitals; Support HR 6693 Critical Access Hospital Expansion Act of 2020, a bill to amend title XVIII of the Social Security Act to allow States to certify certain hospitals as necessary providers for purposes of designating such hospitals as critical access hospitals under the Medicare program; Support HR 6753/ S 3615 Rural Community Hospital Demonstration Extension Act of 2020, a bill to amend the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to extend the rural community hospital demonstration program; Letter urging CMS to use its authority to extend to LTCHs the existing 20% hospital add-on payment for Medicare beneficiaries diagnosed with COVID-19; Letter to CMS urging the agency to temporarily extend certain waivers and make others permanent beyond the COVID-19 public health emergency to allow hospitals to provide better and more cost effective care to their patients and communities; Sent comment letter to CMS about our concerns with the timeline proposed for implementation as well as the potential for penalties for noncompliance within this timeline on the Medicare Program: Electronic Prescribing of Controlled Substances; Sent comment letter on the FY 2021 Inpatient PPS proposed rule addressing CMS proposals related to payer-specific negotiated rate data collection, Medicare DSH payments, CAR T, bad debt, MS-DRG classifications, and quality programs, among other topics. Letter requesting that the CMS delay the implementation of the Appropriate Use Criteria for Advanced Diagnostic Imaging Services program to allow providers the opportunity to implement and test operational changes and acquire the education necessary to achieve compliance with the program; Sent comments to the CMS on the agencys long-term care hospital prospective payment system proposed policy changes and fiscal year 2021 rates; Letter to CMS asking for a delay in the start of repayments associated with the Medicare Accelerated and Advance Payment (AAP) Programs; Letter urging the CMS to continue its suspension of medical review activities throughout the ongoing COVID-19 public health emergency; Letter urging CMS to allow periodic interim payment (PIP) hospitals to carry out their accelerated payment repayment at cost settlement, as was initially communicated by the agency and also request that the agency make alternative repayment approaches available, such as direct payments to the Medicare Administrative Contractor (MAC), for all hospitals; Comment letter on CY 2021 Home Health Prospective Payment System Rate Update proposed rule. While we continue to support the PDGM objective of increasing HH PPS payment accuracy, we remain concerned that CY 2020s large behavioral offset, 4.36%, was implemented on a prospective basis; Letter urging the CMS to withdraw the condition of participation (CoP) that hospitals report daily COVID-19 data and request that CMS immediately release detailed interpretive guidance so hospitals can take the necessary steps to come into compliance; Urged CMS to withdraw its Medicaid fiscal accountability proposed rule from its regulatory agenda because it would "severely curtail the availability of health care services to millions of individuals" and "many of its provisions are not legally permissible;" Submitted comment letter that disagree with CMS interim APC assignments of COVID-19 vaccine administration services to these New Technology APCs because they are inconsistent with longstanding CMS policy; Submitted comments responding to a CMS request for information on regulatory relief to support economic recovery urging the agency to take additional action to remove certain regulatory barriers standing in the way of efficiency and innovation, thus allowing hospitals to provide better and more cost-effective care to our patients and communities. In order to achieve these objectives, we ask the agency to temporarily extend certain waivers and make others permanent beyond the duration of the COVID-19 public health emergency; Urged a delay implementation of CMS price transparency rule and also asked the Biden Transition team for enforcement discretion with the rule; Letter urging Congress to include in the year-end legislation an extension of the congressionally-enacted moratorium on the application of the Medicare sequester cuts into 2021 and through the duration of the public health emergency (PHE); Letter urging Congress to continue to support the movement to value by ensuring that clinicians in advanced alternative payment models (APMs) continue to receive incentives established under the bipartisan Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); Support S 5044, The Improving Seniors Timely Access to Care Act of 2020, a bill to amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans; Submitted a comment letter, urging CMS not to finalize proposals that would allow states to create a new type of direct enrollment marketplace in lieu of Healthcare.gov or a state-based marketplace. In addition, we do not support the codification in regulation of previous Section 1332 guidance that could allow states to pursue alternative approaches to coverage that would result in coverage losses; Support efforts to protect patients from surprise medical bills by including the No Surprises Act as part of the year-end legislative package; Submitted COVID-19 snapshot report for Congress to better understand the needs of hospitals and health systems during the public health emergency, which combines important data points with news articles and testimonials from the field to reiterate the dire circumstances hospitals and health systems face, and highlight why additional relief is necessary; Submitted comments in response to HRSAs proposal to include additional counties as eligible to receive Federal Office of Rural Health Policy (FORHP) grants, encouraged the agency to use a definition of rural that is inclusive and flexible, in order to broaden opportunities for providers in rural communities and urged HRSA to increase rural grant opportunities.
Client expense: $4,460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Discussions involving Medicare bad debt/uncompensated care payments to hospitals Discussions pertaining to status of Tennessee's Medicaid Block Grant waiver application Monitored CMS Medicaid Fiscal Accountability Regulation (MFAR) rulemaking activity Monitored S 4329 Patient Access to Higher Quality Health Care Act of 2019 Monitored HR 3062 Patient Access to Higher Quality Health Care Act of 2019 Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Medicare Graduate Medical Education payments H.R. 1763/S. 348, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions H.R. 3414, "Opioid Workforce Act" - provisions related to expanding Medicare funding for opioid or pain management residency programs Site-neutral payment policies H.R. 1384/S. 1129, Medicare for all and other public option alternative proposals H.R. 2452, Medicare for America Act of 2010 - provisions related to establishment of a Medicare for America health program to provide for comprehensive health coverage for all Americans H.R. 2463/S. 1261, Choose Medicare Act - provisions related to the establishment of Medicare part E public health plans H.R. 2000/S. 981, Medicare-X Choice Act of 2019 - provisions related to the establishment of a public health plan H.R. 2085/S. 1033, CHOICE Act - provisions amending the Public Health Service Act to establish a public health insurance option S. 470, Medicare at 50 Act - provisions related to amending title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 - provisions related to providing for an option for individuals who are ages 50 to 64 to buy into Medicare and to provide for health insurance market stabilization H.R. 3, "Lower Drug Costs Now Act" S. 2543, "the Prescription Drug Pricing Reduction Act" H.R. 3235, "Access to Genetic Counseling Act" H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to increasing the number of Medicare-funded residency positions, to Medicare, Medicaid, and COVID response Legislative proposals aimed at combating coronavirus impacting Medicare and Medicaid programs
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Insurance
Monitor Medicare for All discussions: H.R. 1384, Medicare for All Act of 2019; S 1129, Medicare for All Act of 2019
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policy Medicare hospital prospective payment system Site-neutral payment policies H.R. 1384/S. 1129, Medicare for All and other public option alternative proposals H.R. 2452, Medicare for America Act of 2010 provisions related to establishment of a Medicare for America health program to provide for comprehensive health coverage for all Americans H.R. 2463/S. 1261, Choose Medicare Act - provisions related to the establishment of Medicare part E public health plans H.R. 2000/S. 981, Medicare-X Choice Act of 2019 - provisions related to the establishment of a public health plan H.R. 2085/S. 1033, CHOICE Act - provisions amending the Public Health Service Act to establish a public health insurance option S. 470, Medicare at 50 Act - provisions related to amending title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 - provisions related to providing for an option for individuals who are ages 50 to 64 to buy into Medicare and to provide for health insurance market stabilization H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to Medicare and Medicaid Legislative proposals aimed at combating coronavirus impacting Medicare and Medicaid programs
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policy Medicare payments for Graduate Medical Education H.R. 1763/S. 348, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions Proposed cuts and policy changes to Medicare Advantage insurance plans H.R. 1384/S. 1129, Medicare for All and public option alternative proposals S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to Medicare and Medicaid and COVID response Legislative proposals aimed at combating coronavirus impacting Medicare and Medicaid programs
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community
Client expense: $22,290,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policy Star Rating System methodology and suspension of the display of overall star ratings on Hospital Compare while the agency continues its important work of enhancing the validity and meaningfulness of star ratings H.R. 1763/S. 348, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions Site-neutral payment policies Oppose H.R. 1384/S. 1129, Medicare for All - provisions related to establishment of a national health insurance program Oppose H.R. 2452, Medicare for America Act of 2010 provisions related to establishment of a Medicare for America health program to provide for comprehensive health coverage for all Americans Oppose H.R. 2463/S. 1261, Choose Medicare Act - provisions related to the establishment of Medicare part E public health plans Oppose H.R. 2000/S. 981, Medicare-X Choice Act of 2019 - provisions related to the establishment of a public health plan Oppose H.R. 2085/S. 1033, CHOICE Act - provisions amending the Public Health Service Act to establish a public health insurance option Oppose S 470, Medicare at 50 Act - provisions related to amending title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare Oppose H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 - provisions related to providing for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to Medicare Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus impacting Medicare and Medicaid programs H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to Medicare and hospitals
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Affordable Care Act (Public Law 111-148). Healthcare Reform, generally. Health Savings Accounts, generally. Small Business Health Plans/Association Health Plans. Employer Sponsored Health Care, generally. Tax exclusion for employer-sponsored health insurance, generally. H.R. 1922/S. 1089: The Restoring Access to Medications Act. HHS (reg) title: Department of Health and Human Services blueprint to lower drug prices and reduce out-of-pocket costs (RIN 0991- ZA49). Health care costs, generally. Innovations and diversity of plan designs and offerings for employees. Surprise medical bills, generally. Tax-preferred status for over the counter medications, generally. H.R. 1384: Medicare for All Act of 2019. H.R. 2782/S. 1510: Employee Flexibility Act of 2019. H.R. 2447: Jobs and Premium Protection Act. S. 1895: Lower Health Care Costs Act. Single-payer health care system. Medicare/Medicaid buy-in program. H.R. 4070/S. 2366: the Commonsense Reporting Act of 2019. IRS (Reg) Title: Health Reimbursement Arrangements and Other Account-Based Group Health Plans (RIN 0938-AT90). IRS (Reg) Title: Application of Employer Shared Responsibility Provisions and Certain Nondiscrimination Rules to Health Reimbursement Arrangements and Other Account-Based Group Health Plans Integrated with Individual Health Insurance Coverage or Medicare (RIN 1545-BP17). IRS (Notice) Title: Transition Relief Related to Health Coverage Reporting Required by I.R.C. Sections 6055 and 6056 for 2019 (Notice 2019-63). Employee Retirement Income Security Act of 1974. Health Reimbursement Arrangements (REG-136401-18) and Notice 2019-63. H.R. 1185: Family and Medical Insurance Leave Act. H.R. 6198: Emergency Paid Leave Act of 2020. HHS (Proposed Rule): Title: Transparency in Coverage (CMS-9915-P). H.R. 5800: Ban Surprise Billing Act. Family and Medical Leave Act. H.R. 6201: the Families First Coronavirus Response Act. H.R. 748/S.3548: the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Increase Telehealth Coverage and Care. Affordable Employer-Sponsored Coverage through COBRA. Flexible spending arrangements. Affordable Care Act Employer Shared Responsibility (Section 4980H) & Reporting Requirements (Sections 6055 and 6056) and Federal Reporting and Filings under Department of Labor, Treasury, Health and Human Services. H.R. 7666: Family Savings Flexibility Act. S. 4317: SAFE TO WORK Act. Executive Order 13954: Saving Lives Through Increased Support for Mental-and Behavior-Health Needs. S. 1985: Lower Health Care Costs Act. COVID-19 safe harbor and flexibility measures under ACA Code Section 4980H. HHS-CMS (Reg) Title: Patient Protection and Affordable Care Act and 2022 Notice of Benefit and Payment Procedures [CMS-9914-P] [RIN 0938-AU18]. "No Surprise Act" in H.R. 133, the Consolidated Appropriations Act, 2021. IRS Review of Regulatory and other Relief to Support Economic Recovery, E.O 13924.
Client expense: $620,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Economic Council (NEC), Navy, Dept of, Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Medicare Graduate Medical Education payments H.R. 1763/S. 348, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions H.R. 3414, "Opioid Workforce Act" - provisions related to expanding Medicare funding for opioid or pain management residency programs Site-neutral payment policies H.R. 1384/S. 1129, Medicare for all and other public option alternative proposals H.R. 2452, Medicare for America Act of 2010 provisions related to establishment of a Medicare for America health program to provide for comprehensive health coverage for all Americans H.R. 2463/S. 1261, Choose Medicare Act - provisions related to the establishment of Medicare part E public health plans H.R. 2000/S. 981, Medicare-X Choice Act of 2019 - provisions related to the establishment of a public health plan H.R. 2085/S. 1033, CHOICE Act - provisions amending the Public Health Service Act to establish a public health insurance option S. 470, Medicare at 50 Act - provisions related to amending title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 - provisions related to providing for an option for individuals who are ages 50 to 64 to buy into Medicare and to provide for health insurance market stabilization H.R. 3, "Lower Drug Costs Now Act" H.R. 3235, "Access to Genetic Counseling Act"
Client expense: $398,118 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Medicare/Medicaid
H.R. 803 / S. 988, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act; H.R. 1034 / S. 640, Phair Pricing Act of 2019; H.R. 1035, Prescription Drug Price Transparency Act, S. 475, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 476, Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act; H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs; H.R.448 / S. 99, Medicare Drug Price Negotiation Act; H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019; H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019; H.R. 366, Insulin Access for All Act of 2019; S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019; S. 205 / H.R. 937, Right Rebate Act of 2019; H.R. 1046 / S. 377, Medicare Negotiation and Competitive Licensing Act of 2019; H.R. 1781 / S. 801, the Payment Commission Data Act of 2019; H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019; H.R. 2115, To amend title XI of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers; Proposed rule, "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS-4180-P"; Proposed rule, "Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees, OIG-0936-P"; Proposed rule, Medicaid Program; Medicaid and Childrens Health Insurance Plan (CHIP) Managed Care - CMS-2408-P; H.R. 1323, Rural Hospital Frontier Fairness Act; S. 551, REFUND Act of 2019; S. 691, Medicare Extra Rx HELP Act of 2019; S. 773, Telehealth Innovation and Improvement Act of 2019; S. 814, Expanding Access to Diabetes Self-Management Training Act of 2019; H.R. 1384 / S. 1129, Medicare for All Act of 2019; H.R. 3417, The Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019; H.R. 3408, Shop Rx Act of 2019; S. 1384, Prescription Drug Rebate Reform Act of 2019; H.R. 2113, Prescription Drug STAR Act; H.R. 2115, Public Disclosure of Drug Discounts Act S. 2447, the Phair Relief Act; S. 2771, the Protecting Home Oxygen and Medical Equipment Act of 2019; S. 1861 / H.R. 3924, the Streamlining Part D Appeals Process Act; H.R. 4946, the Ensuring Seniors Access to Local Pharmacies Act of 2019; H.R. 5281, the Drug Price Transparency in Medicaid Act of 2019; H.R. 5442, the Lowest Price for Patients Act; Report language for H.R.1865, the Further Consolidated Appropriations Act; Pharmacist Provider Status draft legislation
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2020 · fourth_quarter · Health Issues
S.80, Jobs and Premium Protection Act (all provisions) S.172, Health Insurance Tax Relief Act (all provisions) S.340, CREATES Act (all provisions) S.684, Middle Class Health Benefits Tax Repeal Act (all provisions) S.1531, Stopping the Outrageous Practice of Surprise Medical Bills Act (all provisions) S.1895, Lower Health Care Costs Act S.1510, Employee Flexibility Act (all provisions) S.2366, Commonsense Reporting Act (all provisions) HR 6800, Heroes Act HR 748, Middle Class Health Benefits Tax Repeal Act (all provisions) HR 861, End Surprise Billing Act (all provisions) HR 965, CREATES Act (all provisions) HR 1384, Medicare for All Act (all provisions) HR 1398, Health Insurance Tax Relief Act (all provisions) HR 3630, No Surprises Act HR 2782, Employee Flexibility Act (all provisions) HR 4070, Commonsense Reporting Act (all provisions) HR 3502, Protecting People From Surprise Medical Bills Act (all provisions) S.2543 Prescription Drug Pricing Reduction Act (all provisions) H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (all provisions) H.R. 1994, the Setting Every Community Up for Retirement Enhancement (SECURE) Act (all provisions) H.R. 1865, Consolidated Appropriations Act (surprise billing provisions) H.R. 133, Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (all provisions)
Client expense: $1,660,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Equal Employment Opportunity Commission (EEOC), Federal Maritime Commission, Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Maritime Administration (MARAD), Natl Economic Council (NEC), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Medicare/Medicaid
Monitor the following: H.R.1046, Medicare Negotiation and Competitive Licensing Act, Entirety H.R.1384/S.1129, Medicare for All Act of 2019, Entirety H.R.2452, Medicare for America Act of 2019, Entirety Federal Medicaid Funding (FMAP) increase
Client expense: $370,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
S. 4840 Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 HR 133 The Consolidated Appropriations Act HR 6800 the HEROES Act re COVID relief S. 4163 re COVID Testing (Gardner) S. 4329 Continuous Health Coverage for Workers Act (McSally) HR 7472 re contract tracing (Speier) S. 4230 Telehealth Expansion Act (Wyden) HR 6395, National Defense Authorization Act S. 4049, National Defense Authorization Act HR 6666, COVID 19 Testing, Reaching and Contacting Everyone Act (TRACE Act) HR 1425, Patient Protection and Affordable Care Enhancement Act HR 6514, Worker Health Coverage Protection Act HR 6568, Coverage for COVID 19 Treatment Act HR 5438, Cox, The End Valley Fever Now Act S. 2897, Warner, regarding the reauthorization of PCORI HR 5201, Matsui, regarding telehealth and behavioral health HR 2328, the No Surprises Act S. 1895, the Lower Health Care Costs Act HR 987 and S. 455, regarding outreach and education activities under the ACA HR 3439, regarding the reauthorization of PCORI House Resolution 271, regarding the Justice Departments position in Texas v. United States HR 2062 & S. 1012, regarding 42 CFR Part 2 and confidentiality of certain health information HR 1884, with provisions to stabilize and strengthen the ACA and the nongroup insurance market. S. 470, regarding a Medicare buy-in option for individuals aged 50-64 S. 489 and HR 1277, regarding a Medicaid buy-in option S. 1129, to establish a single payer system based on Medicare for All. HR 1384, to establish a single payer health care system HR 1425, regarding reinsurance funding under the ACA HR 986 and S. 466, regarding Section 1332 state waiver guidance. HR 1010, regarding Short Term Limited Duration Insurance policies HR 1143, regarding Short Term Limited Duration Insurance policies HR 861, regarding surprise billing
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
Affordable Healthcare Act (ACA)Regulations; ACA Stabilization; American Health Care Act (AHCA); Health Care Reform; Reinsurance; Health Savings Accounts; Repeal and Replace; Grace Periods; SEPs; Medicare Cost plan; Marketplace Stability; Individual Marketplace Reform; Better Care Reconciliation Act (BCRA), mental health, transparency, HSA, Opioids, CREATES Act, Drug Pricing; Prescription Drug Costs Rebates, Telehealth,Surprise Billing, COVID19-Response Relief Packages; Healthcare Access/privacy,COVID-19 Response and Relief Packages, COVID-19 Testing, COVID-19 Vaccine Strategy and Treatment HR 1346 -Medicare Buy-In and Health Care Stabilization Act of 2019 HR1384 Medicare for All Act of 2019 HR 986 Protecting People from Preexisting Conditions Act HR 965 CREATES Act of 2019 HR 3502 Protecting people from Surprise Medical Bills HR 987 Strengthening Health Care and Lowering Prescription Drug Costs HR 1499 Patient Consumer Access to Generic Drugs Act HR 1425 State Health Care Premium Reduction Act S 1895 Lower Health Care Costs Act HR 3630 No Surprises Act Public Law 116-123 First Coronavirus Response Act HR6545 Health Insurance Marketplace Affordability Act of 2020
Client expense: $24,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Protecting America's Workers Act H.R. 1074 Never Forget the Heroes: Permanent Authorization of the September 11th Victim Compensation Fund Act S. 546; H.R. 1327 Medicare for All Act of 2019 S. 1129, H.R. 1384 Coronavirus Aid, Relief, and Economic Security Act (CARES Act) S. 3548, H.R.748 Health and Economic Recovery Omnibus Emergency Solutions Act H.R. 6800
Client expense: $35,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
assist client with issues pertaining to medicare and medicaid. HR6674 Medicare Crisis Program 2020; S3864 Medicare Mental Health Inpatient Equity Act of 2020; HR6811 WIC Act 2020; HR6445,S3563 Food Assistance for Kids and Families during COVID 2020.HR 6281, S3500 Medicare Wage Index Parity Act 2020; HR 4618 Medicare Hearing Act;HR913 Clinical Treatment Act 2019; HR1264 Payment Commission Data Act 2019; HR1390 Mobile Health Record Act; HR1394 Medigap Consumer Protection 2019; HR1409 Transparency in all Healthcare Pricing Act 2019; HR1425 Patient Protection & Affordable Care Act; S470 Medicaid at 50 Act; S773 Telehealth Innovation and Improvement Act; S377 Medicare Negotiation and Competitive Licensing Act 2019; S618 Medicare Choices Empowerment and Protection Act.; S1114 Medicare Adv Quality Payment Relief Act; H.R.2564 Medicare Enrollment Protection Act; H.R.275 Medicare Prescription Drug Price Negotiation Act of 2019;H.R.884 Medicare Mental Health Access Act; H.R.3127 Medicare Home Health Flexibility Act; H.R.1384 Medicare for All Act of 2019.
Client expense: Not reported · Firm income: $11,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Contacts in support of regulatory changes to enforce the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance. Contacts in opposition to Medicare for All legislation (H.R. 1384 and S. 1129) because they mandate government coverage of abortions and are likely to require hospitals and doctors to perform abortion procedures. Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal. Contacts regarding strengthening guidance to providers against steering patients away from treatment. Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market. Contacts in opposition to H.R. 1425 which includes: 1) Permanent tax credit increases to the Patient Protection and Affordable Care Act; 2) A new federal reinsurance program run by states without Hyde-like protections; and 3) Prescription drug price controls that will lead to the rationing of treatment; letter to the House dated June 29, 2020. Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Client expense: $70,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Council on Disability, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
2020 · fourth_quarter · Health Issues
Treatment of tax-preferred savings accounts, transit benefits and the employer exclusion for health benefits. Excise Tax. H.R.2452 - Medicare for America Act of 2019 H.R.1384 - Medicare for All Act of 2019 S.1129 - Medicare for All Act of 2019 Support for COBRA benefits H.R. 748 - HEROES Act Administration rules to improve HRAS H.R. 600 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Health, Economic Assistance, Liability Protection and Schools (HEALS) Act Delivering Immediate Relief to America's Families, Schools and Small Business Act (Senate Amendment No. 2652 to the House Amendment S. 178) H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
2020 · fourth_quarter · Pharmacy
H. R. 133 (Consolidated Appropriations Act): Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes. H.R. 925 (HEROES): Coronavirus Recovery Supplemental Appropriations H.R.6800 (HEROES): Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes. HR 2477 (BENES): To amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. HR 3: A bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. HR 3276: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. HR 2113: A bill to a mend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes. S. 1895: A bill to lower health care costs by preventing surprise medical bills, reducing prescription drug prices, improving transparency in health care, investing in public health and improving health information exchange. H.R. 1384: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 1129: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 981: A bill to establish a public health plan. HR 938: A bill to amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes HR 1520: A bill to amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes. HR 1503: A bill to amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes. HR 1499: A bill prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes. HR 965: promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. H.R. 3: An act to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S. 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
2020 · fourth_quarter · Taxation/Internal Revenue Code
H. R. 133 (Consolidated Appropriations Act): Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes. H.R. 2477 (Benes Act of 2020): To amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. S. 4318: A bill to create $1,200 stimulus check, for individuals with incomes up to $75,000 the same as in the CARES Act. The bill also contains the supplemental employment benefits, with $600 per week through July 31, $200 per week through October 5th, and then becomes a payment of 70% of lost wages though December 31 S. 4317: A bill to establish a COVID-19 liability shield for employers. S. 4321: A bill which extends he Paycheck Protection Program, providing money for additional loans, while reserving loans only for companies with under 300 employees and at least a 50% reduction in gross receipts S. 4320: An appropriations bill, contains a total of $306 billion in discretionary spending S. 2733: A bill to set up committees to produce a report regarding the financial health of the various federal trust funds S. 4322: A bill to defer student loan payments for borrowers with no income, funds scholarships for students returning to and starting at private schools, includes provisions related to medical stockpiles, diagnostic testing, and disease surveillance S. 4324: A bill to decrease the United States' dependence on foreign countries for personal protective equipment manufacturing, tighten oversight of federally funded research, and others. S. 4319: A bill to allow businesses to deduct 100% of the cost of business meals in 2020, compared to the current 50% tax deduction S. 1531: A bill to amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing. HR 5800: A bill to end surprise medical billing and increase transparency in health coverage. H.R. 925 (HEROES): Coronavirus Recovery Supplemental Appropriations H.R.6800 (HEROES): Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes. HR 2477 (BENES): To amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. HR 6201 (FFCRA): A bill making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes. HR 748 (CARES): This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. S. 3548 (CARES): A bill to provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic. HR 3: A bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. HR 4070: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. S. 2366: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. HR 3796: A bill to amend the Internal Revenue Code of 1986 to provide that coverage under Medicare is permissible for purposes of contributions to health savings accounts. HR 861: A bill to amend title XVIII of the Social Security Act to prevent surprise billing practices, and for other purposes. HR 3276: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. HR 2113: A bill to amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes. H.R. 2782: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. S. 1510: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. H.R.2564: This bill creates a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA)-a federal law that allows an individual to maintain health coverage following loss of coverage due to termination of employment or another qualifying event. H.R. 1682: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. S. 753: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. H.R. 1384: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 1129: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 981: A bill to establish a public health plan. H.R. 1346: To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. S. 470: To amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare. S. 1895: A bill to lower health care costs by preventing surprise medical bills, reducing prescription drug prices, improving transparency in health care, investing in public health and improving health information exchange. H.R. 3630: To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
2020 · fourth_quarter · Health Issues
H. R. 133 (Consolidated Appropriations Act): Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes. H.R. 2477 (Benes Act of 2020): To amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. S. 4318: A bill to create $1,200 stimulus check, for individuals with incomes up to $75,000 the same as in the CARES Act. The bill also contains the supplemental employment benefits, with $600 per week through July 31, $200 per week through October 5th, and then becomes a payment of 70% of lost wages though December 31 S. 4317: A bill to establish a COVID-19 liability shield for employers. S. 4321: A bill which extends he Paycheck Protection Program, providing money for additional loans, while reserving loans only for companies with under 300 employees and at least a 50% reduction in gross receipts S. 4320: An appropriations bill, contains a total of $306 billion in discretionary spending S. 2733: A bill to set up committees to produce a report regarding the financial health of the various federal trust funds S. 4322: A bill to defer student loan payments for borrowers with no income, funds scholarships for students returning to and starting at private schools, includes provisions related to medical stockpiles, diagnostic testing, and disease surveillance S. 4324: A bill to decrease the United States' dependence on foreign countries for personal protective equipment manufacturing, tighten oversight of federally funded research, and others. S. 4319: A bill to allow businesses to deduct 100% of the cost of business meals in 2020, compared to the current 50% tax deduction S. 1531: A bill to amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing. HR 5800: A bill to end surprise medical billing and increase transparency in health coverage. H.R. 925 (HEROES): Coronavirus Recovery Supplemental Appropriations H.R.6800 (HEROES): Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes. HR 2477 (BENES): To amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. HR 6201 (FFCRA): A bill making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes. HR 748 (CARES): This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. S. 3548 (CARES): A bill to provide emergency assistance and health care response for individuals, families, and businesses affected by the 2020 coronavirus pandemic. HR 3: A bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. HR 4070: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. S. 2366: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. HR 3796: A bill to amend the Internal Revenue Code of 1986 to provide that coverage under Medicare is permissible for purposes of contributions to health savings accounts. HR 861: A bill to amend title XVIII of the Social Security Act to prevent surprise billing practices, and for other purposes. HR 3276: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. HR 2113: A bill to amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes. H.R. 2782: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. S. 1510: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. H.R.2564: This bill creates a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA)-a federal law that allows an individual to maintain health coverage following loss of coverage due to termination of employment or another qualifying event. H.R. 1682: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. S. 753: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. H.R. 1384: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 1129: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 981: A bill to establish a public health plan. H.R. 1346: To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. S. 470: To amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare. S. 1895: A bill to lower health care costs by preventing surprise medical bills, reducing prescription drug prices, improving transparency in health care, investing in public health and improving health information exchange. H.R. 3630: To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office